<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-14T12:13:03Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/7578" metadataPrefix="mods">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/7578</identifier><datestamp>2023-03-23T01:05:15Z</datestamp><setSpec>com_10259_6256</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_6257</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Fernández-Lázaro, Diego</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Seco-Calvo, Jesús</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Pascual-Fernández, Jorge</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Domínguez-Ortega, Carlos</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Valle Soto, Miguel del</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Mielgo Ayuso, Juan</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2023-03-22T07:43:23Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2023-03-22T07:43:23Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2022-12</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="uri">http://hdl.handle.net/10259/7578</mods:identifier>
<mods:identifier type="doi">10.3390/ijerph192316158</mods:identifier>
<mods:identifier type="essn">1660-4601</mods:identifier>
<mods:abstract>Tribulus terrestris L. (TT) ingredients have anti-inflammatory and antioxidant activities,&#xd;
but their effects on exercise-induced muscle damage (EIMD) in trained athletes are uncertain. The&#xd;
purpose of this single-blind placebo-controlled trial, in accordance with CONSORT guidelines,&#xd;
was to examine the effect of 6 weeks of TT supplementation on muscle metabolism, inflammation&#xd;
biomarkers, and oxidant status. Thirty trained male CrossFit® athletes were randomly assigned to be&#xd;
supplemented with 770 mg/day of TT (intervention group (IG)) or receive a placebo daily (control&#xd;
group (CG)) for 6 weeks. Muscle damage enzymes, inflammation biomarkers, and Total Antioxidant&#xd;
Status (TAS) were assessed at baseline (T1), 21 days after baseline (T2), and after 42 days (T3). Grace, a&#xd;
Workout of the Day, was measured in T1 and T3. Statistical significance (p &lt; 0.05) was found between&#xd;
IG and CG in Lactate Dehydrogenase (LDH), C-reactive protein (CRP), and TAS levels at the end of&#xd;
the follow-up. Furthermore, TAS levels were significantly (p &lt; 0.05) lower at T2 and T3 relative to&#xd;
baseline in the IG, also LDH and CRP increased significantly (p &lt; 0.05) at T2 and T3 relative to baseline&#xd;
in the CG. No significant (p > 0.05) decreases in muscle damage or inflammation biomarkers were&#xd;
observed, although a slight downward trend was observed after 6 weeks for supplemented athletes.&#xd;
TT supplementation could attenuate the CrossFit® training program-induced oxidative stress, muscle&#xd;
damage, and inflammation which could be due to the natural antioxidant and anti-inflammatory&#xd;
properties of TT.</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by/4.0/</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">Atribución 4.0 Internacional</mods:accessCondition>
<mods:subject>
<mods:topic>Tribulus terrestris L.</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Herbal supplementation</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Crossfit</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Muscle damage</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Inflammation response</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Exercise-induced oxidative stress</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>6-Week Supplementation with Tribulus terrestris L. to Trained Male CrossFit® Athletes on Muscle, Inflammation, and Antioxidant Biomarkers: A Randomized, Single-Blind, Placebo-Controlled Trial</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>